BiotechTube
CellVoyant

CellVoyant

Bristol, United Kingdom· Est.
cellvoyant.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20.2M

Overview

CellVoyant is a private, early-stage biotech applying artificial intelligence to the development of cell therapies. The company's core technology uses AI to analyze live cell images and predict future biological outcomes, enabling more efficient process development and earlier decision-making for its clients. Its business model combines a SaaS-style predictive analytics platform, FateView™, with a bespoke optimization service, FateDrive™, targeting biopharma companies engaged in cell therapy R&D. Founded in 2021, the company is pre-revenue and focused on validating its technology with industry partners.

AI / Machine Learning

Technology Platform

AI-driven predictive cell analytics platform using live-cell imaging to forecast future cell states and Critical Quality Attributes (CQAs).

Funding History

2
Total raised:$20.2M
Seed$16M
Seed$4.2M

Opportunities

The rapid growth of the cell therapy market, plagued by inefficient and costly development processes, creates a large addressable market for enabling technologies.
CellVoyant's AI platform can deliver significant value by reducing failed experiments, accelerating timelines, and improving manufacturing yields, offering a strong return on investment for therapy developers.

Risk Factors

Key risks include the technical challenge of validating AI predictions across diverse biological systems, slow adoption by a conservative industry, and intense competition from other AI biotech startups and established life science tool companies.
As a pre-revenue startup, it also faces financial risk dependent on venture funding.

Competitive Landscape

Competition includes other AI/ML startups focused on cell image analysis (e.g., Deepcell, Cellarity), large life science tool providers integrating AI into their offerings (e.g., Sartorius, Revvity), and in-house AI efforts at large biopharma companies. CellVoyant differentiates through its integrated biology-AI team and dual platform/service model focused specifically on predictive cell fate analytics.

More companies in AI / Machine Learning →More companies in United Kingdom →